Bellevue Asset Management, Llc
Source: SEC Form 13F · as of Mar 2026Bellevue Asset Management, Llc holds 20 biotech & pharma companies tracked by BioSniper, totaling $4.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$4.9M
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 5,076 | $1.8M |
| ABTABBOTT LABORATORIES | 13,482 | $1.4M |
| LLYELI LILLY & Co | 572 | $526K |
| JNJJOHNSON & JOHNSON | 1,370 | $335K |
| BMYBRISTOL MYERS SQUIBB CO | 4,395 | $267K |
| ADPTAdaptive Biotechnologies Corp | 10,335 | $143K |
| GILDGILEAD SCIENCES, INC. | 685 | $96K |
| MRKMerck & Co., Inc. | 720 | $87K |
| AYTUAYTU BIOPHARMA, INC | 25,013 | $68K |
| CORCencora Inc. | 166 | $52K |
| PFEPFIZER INC | 1,418 | $40K |
| LNTHLantheus Holdings, Inc. | 475 | $36K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 482 | $27K |
| REGNREGENERON PHARMACEUTICALS, INC. | 27 | $21K |
| SLSSELLAS Life Sciences Group, Inc. | 2,512 | $11K |
| ABBVAbbVie Inc. | 35 | $8K |
| ALTAltimmune, Inc. | 2,433 | $7K |
| TEVATeva Pharmaceutical Industries Limited | 200 | $6K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 22 | $6K |
| NVONovo Nordisk A/S | 58 | $2K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.